CoChat
Sign Up
Cited by 48

The DOI matches its Crossref record.

Role of enolase-1 in response to hypoxia in breast cancer: Exploring the mechanisms of action

GAO, JIE, ZHAO, RONGRONG, XUE, YAN, NIU, ZUOXING, CUI, KAI, YU, FACHANG, ZHANG, BO, LI, SHENG·2013·Oncology Reports
DOI 10.3892/or.2013.2269
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3892/or.2013.2269

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ENO1, as a moonlighting protein, performs multiple biological functions in cancer development, such as gene regulation, protein synthesis, cascade signalling pathway activation, immune responses, host-pathogen interactions, chemotherapy resistance, and cellular stress responses.

    “ENO1, as a moonlighting protein, performs multiple biological functions in cancer development”

    From ENO1–BACE2-mediated LDLR cleavage promotes liver cancer progression by remodelling cholesterol metabolism (2025) · cites this paper as Gao et al., 2013

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 31

  1. Gordan, 2007, Hypoxia-inducible factors: central regulators of the tumor phenotype, Curr Opin Genet Dev, 17, 71, 10.1016/j.gde.2006.12.006 · DOI
  2. España, 2005, Bcl-x(L)-mediated changes in metabolic pathways of breast cancer cells: from survival in the blood stream to organ-specific metastasis, Am J Pathol, 167, 1125, 10.1016/S0002-9440(10)61201-1 · DOI
  3. Zhang, 2005, Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer, Mol Cell Proteomics, 4, 1686, 10.1074/mcp.M400221-MCP200 · DOI
  4. Wu, 2006, Proteomic analysis of paclitaxel-induced apoptosis in MCF-7 human breast carcinoma cells, Zhonghua Zhong Liu Za Zhi, 28, 418
  5. Dowling, 2007, Proteomic analysis of isolated membrane fractions from superinvasive cancer cells, Biochim Biophys Acta, 1774, 93, 10.1016/j.bbapap.2006.09.014 · DOI
  6. Yoo, 2004, Proteomic analysis of carbonylated proteins in two-dimensional gel electrophoresis using avidin-fluorescein affinity staining, Electrophoresis, 25, 1334, 10.1002/elps.200405890 · DOI
  7. Cavdar, 2010, In vitro reoxygenation following hypoxia increases MMP-2 and TIMP-2 secretion by human umbilical vein endothelial cells, Acta Biochim Pol, 57, 69, 10.18388/abp.2010_2374 · DOI
  8. Scharte, 2003, Cytokines induce HIF-1 DNA binding and the expression of HIF-1-dependent genes in cultured rat enterocytes, Am J Physiol Gastrointest Liver Physiol, 284, G373, 10.1152/ajpgi.00076.2002 · DOI
  9. Somiari, 2003, High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast, Proteomics, 3, 1863, 10.1002/pmic.200300560 · DOI
  10. Choi, 2006, Vitexin, an HIF-1alpha inhibitor, has anti-metastatic potential in PC12 cells, Mol Cells, 22, 291, 10.1016/S1016-8478(23)17423-1 · DOI
  11. Yu, 2004, Antiapoptotic action of hypoxia-inducible factor-1α in human endothelial cells, Lab Invest, 84, 553, 10.1038/labinvest.3700071 · DOI
  12. Roland, 2000, Identification of hypoxia-responsive messengers expressed in human microvascular endothelial cells using differential display RT-PCR, Eur J Biochem, 267, 3567, 10.1046/j.1432-1327.2000.01385.x · DOI
  13. Li, 2003, A proteomic study on cell cycle progression of endothelium exposed to tumor conditioned medium and the possible role of cyclin D1/E, Clin Hemorheol Microcirc, 29, 383
  14. Li, 2003, The mitogenic and anti-apoptotic activity of tumor conditioned medium on endothelium, Clin Hemorheol Microcirc, 29, 375
  15. Jaffe, 1973, Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria, J Clin Invest, 52, 2745, 10.1172/JCI107470 · DOI
  16. Hewett, 2001, Identification of tumour-induced changes in endothelial cell surface protein expression: an in vitro model, Int J Biochem Cell Biol, 33, 325, 10.1016/S1357-2725(01)00020-6 · DOI
  17. Jiang, 1997, V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression, Cancer Res, 57, 5328
  18. Kim, 2005, Multifaceted roles of glycolytic enzymes, Trends Biochem Sci, 30, 142, 10.1016/j.tibs.2005.01.005 · DOI
  19. Kircher, 2002, Reduced levels of DEAD-box proteins DBP-RB and p72 in fetal Down syndrome brains, Neurochem Res, 27, 1141, 10.1023/A:1020921324871 · DOI
  20. Wotton, 2001, The Smad transcriptional corepressor TGIF recruits mSin3, Cell Growth Differ, 12, 457
  21. Melhuish, 2001, TGIF2 interacts with histone deacetylase 1 and represses transcription, J Biol Chem, 276, 32109, 10.1074/jbc.M103377200 · DOI · Paper page
  22. Nadimpalli, 2000, Prohibitins, stomatins, and plant disease response genes compose a protein superfamily that controls cell proliferation, ion channel regulation, and death, J Biol Chem, 275, 29579, 10.1074/jbc.M002339200 · DOI
  23. Graven, 2002, Identification of protein disulfide isomerase as an endothelial hypoxic stress protein, Am J Physiol Lung Cell Mol Physiol, 282, L996, 10.1152/ajplung.00359.2001 · DOI
  24. Nowak, 1981, Pyruvate kinase: activation by and catalytic role of the monovalent and divalent cations, Mol Cell Biochem, 35, 65, 10.1007/BF02354821 · DOI
  25. Desrumaux, 1999, Plasma phospholipid transfer protein prevents vascular endothelium dysfunction by delivering α-tocopherol to endothelial cells, FASEB J, 13, 883, 10.1096/fasebj.13.8.883 · DOI
  26. Sun, 1995, Transduction of folate receptor cDNA into cervical carcinoma cells using recombinant adeno-associated virions delays cell proliferation in vitro and in vivo, J Clin Invest, 96, 1535, 10.1172/JCI118192 · DOI
  27. Jiang, 2008, Constructing disease-specific gene networks using pair-wise relevance metric: application to colon cancer identifies interleukin 8, desmin and enolase 1 as the central elements, BMC Syst Biol, 2, 72, 10.1186/1752-0509-2-72 · DOI
  28. Kabbage, 2008, Protein alterations in infiltrating ductal carcinomas of the breast as detected by nonequilibrium pH gradient electrophoresis and mass spectrometry, J Biomed Biotechnol, 2008, 564127, 10.1155/2008/564127 · DOI
  29. Rütters, 2006, Towards a lung adenocarcinoma proteome map: Studies with SP-C/c-raf transgenic mice, Proteomics, 6, 3127, 10.1002/pmic.200500188 · DOI
  30. Sasabe, 2007, The involvement of hypoxia-inducible factor-1alpha in the susceptibility to gamma-rays and chemotherapeutic drugs of oral squamous cell carcinoma cells, Int J Cancer, 120, 268, 10.1002/ijc.22294 · DOI
  31. Moulder, 1987, Tumor hypoxia: its impact on cancer therapy, Cancer Metastasis Rev, 5, 313, 10.1007/BF00055376 · DOI

Cited by

Sorted by citations

Metadata

Authors
GAO, J., ZHAO, R., XUE, Y., NIU, Z., CUI, K., YU, F., ZHANG, B., & LI, S.
Venue
Oncology Reports
Publisher
Spandidos Publications
Published
2013-02-01
Volume
29
Issue
4
Pages
1322-1332
ISSN
  • 1021-335X
  • 1791-2431
DOI
10.3892/or.2013.2269
Cited by
48
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review